Skip to main content
. Author manuscript; available in PMC: 2011 Apr 30.
Published in final edited form as: J Cardiovasc Pharmacol. 2010 Jan;55(1):14–20. doi: 10.1097/FJC.0b013e3181c5e743

Figure 3.

Figure 3

Pressure-Volume Analysis. In Panel A, τ, the isovolemic ventricular relaxation constant, was significantly lower in the BNP group vs HF rats and comparable to Sham rats. In Panel B, ex-vivo EDPVR curves demonstrate an attenuated shift to the right after BNP therapy vs. Sham. HF rats had a slightly greater shift to the right, representative of worsened diastolic properties, that was also confirmed on in-vivo pressure-volume analysis. (* p<0.05 vs. Sham, † p<0.05 vs HF)